These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37451243)
1. Detection of axillary lymphadenopathy after Covid-19 vaccination during breast examination: Case series and review of the literature after one year. Veverková L; Mohelníková-Duchoňová B; Sedláčková Z; Löwová Ľ; Šišola I Cent Eur J Public Health; 2023 Jun; 31(2):110-114. PubMed ID: 37451243 [TBL] [Abstract][Full Text] [Related]
2. Frequency and Characteristics of Nodal and Deltoid FDG and Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000 [No Abstract] [Full Text] [Related]
3. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors. Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425 [No Abstract] [Full Text] [Related]
4. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality. van Nijnatten TJA; Jochelson MS; Lobbes MBI Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513 [TBL] [Abstract][Full Text] [Related]
5. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases. Faermann R; Nissan N; Halshtok-Neiman O; Shalmon A; Gotlieb M; Yagil Y; Samoocha D; Friedman E; Sklair-Levy M Acad Radiol; 2021 Sep; 28(9):1191-1197. PubMed ID: 34257025 [TBL] [Abstract][Full Text] [Related]
6. Post-vaccination SARS-CoV-2 axillary adenopathy. Differences with axillary metastases from breast cancer. Armas-Conde M; Sánchez-Álvarez ÁL; Tejera-Hernández A; Vega-Benítez V; Antela-López JC; Gutiérrez-Giner MI; Hernández-Hernández JR Cir Cir; 2022; 90(3):410-413. PubMed ID: 35636962 [TBL] [Abstract][Full Text] [Related]
7. Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors. Mema E; Lane EG; Drotman MB; Eisen CS; Thomas C; Prince MR; Dodelzon K AJR Am J Roentgenol; 2023 Aug; 221(2):175-183. PubMed ID: 36883774 [No Abstract] [Full Text] [Related]
8. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination. Edmonds CE; Zuckerman SP; Conant EF AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649 [TBL] [Abstract][Full Text] [Related]
9. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation. Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641 [TBL] [Abstract][Full Text] [Related]
11. COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature. Lim J; Lee SA; Khil EK; Byeon SJ; Kang HJ; Choi JA Semin Oncol; 2021; 48(4-6):283-291. PubMed ID: 34836672 [TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy. Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849 [TBL] [Abstract][Full Text] [Related]
14. The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccination. Mukai K; Tsunoda H; Imai R; Numata A; Kida K; Oba K; Yagishita K; Yamauchi H; Kanomata N; Kurihara Y Jpn J Radiol; 2023 Jun; 41(6):617-624. PubMed ID: 36626076 [TBL] [Abstract][Full Text] [Related]
15. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study. Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985 [TBL] [Abstract][Full Text] [Related]
16. Unilateral Axillary Lymphadenopathy after the Inactivated SARS-COV-2 (CoronaVac) Vaccine: Ultrasonographic Imaging. Elverici E; Özsoy A; Sayın B; Gökhan MB; Özkan E Balkan Med J; 2023 Jan; 40(1):28-33. PubMed ID: 36421031 [TBL] [Abstract][Full Text] [Related]
17. US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study. Ha SM; Chu AJ; Lee J; Kim SY; Lee SH; Yoen H; Cho N; Moon WK; Chang JM Radiology; 2022 Oct; 305(1):46-53. PubMed ID: 35471107 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Axillary Lymph Nodes on Breast MRI Before and After COVID-19 Booster Vaccination. Parikh R; Feigin KN; Sevilimedu V; Huayanay J; Pinker K; Horvat JV Acad Radiol; 2024 Mar; 31(3):755-760. PubMed ID: 37037711 [TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccine associated axillary lymphadenopathy - A systematic review. Co M; Wong PCP; Kwong A Cancer Treat Res Commun; 2022; 31():100546. PubMed ID: 35334408 [TBL] [Abstract][Full Text] [Related]